Penn Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-27,077
| Closed | -$2.84M | – | 158 |
|
|
2022
Q4 | $2.84M | Sell |
27,077
-951
| -3% | -$99.8K | 0.29% | 89 |
|
|
2022
Q3 | $2.41M | Buy |
28,028
+23,131
| +472% | +$1.99M | 0.27% | 95 |
|
|
2022
Q2 | $406K | Buy |
4,897
+906
| +23% | +$75.1K | 0.04% | 170 |
|
|
2022
Q1 | $308K | Sell |
3,991
-19
| -0.5% | -$1.47K | 0.03% | 187 |
|
|
2021
Q4 | $354K | Sell |
4,010
-107
| -3% | -$9.45K | 0.04% | 196 |
|
|
2021
Q3 | $318K | Sell |
4,117
-125
| -3% | -$9.66K | 0.03% | 189 |
|
|
2021
Q2 | $354K | Buy |
4,242
+721
| +20% | +$60.2K | 0.03% | 200 |
|
|
2021
Q1 | $266K | Buy |
3,521
+62
| +2% | +$4.68K | 0.03% | 201 |
|
|
2020
Q4 | $303K | Buy |
+3,459
| New | +$303K | 0.04% | 187 |
|